About Acclarent
Acclarent is a company based in Irvine (United States) founded in 2004 was acquired by Integra LifeSciences in December 2023. Acclarent has raised $61 million across 3 funding rounds from investors including Integra LifeSciences, Johnson & Johnson Innovation – JJDC and NEA. The company has 349 employees as of December 31, 2011. Acclarent operates in a competitive market with competitors including Intersect ENT, Tivic Health, Entellus Medical, MyPurMist and Dalent Medical, among others.
- Headquarter Irvine, United States
- Employees 349 as on 31 Dec, 2011
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Acclarent, Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$61 M (USD)
in 3 rounds
-
Latest Funding Round
$26 M (USD), Series D
Jan 12, 2009
-
Investors
Integra LifeSciences
& 6 more
-
Employee Count
349
as on Dec 31, 2011
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Acclarent
Acclarent has successfully raised a total of $61M across 3 strategic funding rounds. The most recent funding activity was a Series D round of $26 million completed in January 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Acclarent
Acclarent has secured backing from 7 investors, including venture fund investors. Prominent investors backing the company include Integra LifeSciences, Johnson & Johnson Innovation – JJDC and NEA.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm backed by Johnson & Johnson
|
Locked | Locked | Locked | |
|
Venture capital investments are offered to startups by NEA.
|
Locked | Locked | Locked | |
|
Investments are made in life sciences firms across all stages.
|
Locked | Locked | Locked |
Investor details for Acclarent
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Acclarent
Investment portfolio details for Acclarent
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Acclarent
Detailed financials for Acclarent
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Acclarent Comparisons
Peer comparison for Acclarent
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Acclarent
Acclarent operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Intersect ENT, Tivic Health, Entellus Medical, MyPurMist and Dalent Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Drug-releasing implants for sinusitis treatment are developed.
|
|
| Locked | Locked | Locked |
Bioelectronic devices for sinusitis pain relief are developed.
|
|
| Locked | Locked | Locked |
Minimally invasive products for chronic sinusitis treatment are developed.
|
|
| Locked | Locked | Locked |
Medical humidification devices are developed with patented CFV technology.
|
|
| Locked | Locked | Locked |
Balloon-based sinus dilation devices are developed for sinusitis treatment.
|
Detailed competitors of Acclarent
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Acclarent
Complete news archive for Acclarent
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Acclarent
Acclarent was founded in 2004 and raised its 1st funding round 1 year after it was founded.
Acclarent is headquartered in Irvine, United States. It is registered at Irvine, California, United States.
Jeff Hopkins is the current CEO of Acclarent.
Acclarent is a funded company, having raised a total of $61M across 3 funding rounds to date.
As of Dec 31, 2011, the latest employee count at Acclarent is 349.
Acclarent was founded in 2004 in Irvine, United States, within the medical device sector. Minimally invasive technologies for ear, nose, and throat procedures are developed by the company, focusing on balloon-based sinuplasty to address rhinosinusitis and persistent Eustachian tube dysfunction. Nasal anatomy is preserved through these tools, which support surgeons in clinical applications across the region.
Acclarent's top competitors include Tivic Health, Intersect ENT and Entellus Medical.
Acclarent has 7 investors. Key investors include Integra LifeSciences, Johnson & Johnson Innovation – JJDC, NEA, Delphi Ventures, and Versant Ventures.